INS and Obesity: Using the conceptual framework outline above, individuals with obesity have been phenotypically characterized as insulin resistant at either the muscle (impaired glucose tolerance, IGT) or liver (impaired fasting glucose, IFG), or both (IGT/IFG) based on their glycemic response to an oral glucose tolerance test [59].